These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 28561694)
61. R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience. Widmer F; Balabanov S; Soldini D; Samaras P; Gerber B; Manz MG; Goede JS Ann Hematol; 2018 Feb; 97(2):277-287. PubMed ID: 29147847 [TBL] [Abstract][Full Text] [Related]
62. Mantle cell lymphoma: state of the art. Skarbnik AP; Goy AH Clin Adv Hematol Oncol; 2015 Jan; 13(1):44-55. PubMed ID: 25679973 [TBL] [Abstract][Full Text] [Related]
63. Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop. Gordon LI; Bernstein SH; Jares P; Kahl BS; Witzig TE; Dreyling M Leuk Lymphoma; 2014 Oct; 55(10):2262-70. PubMed ID: 24512319 [TBL] [Abstract][Full Text] [Related]
64. Bilateral Lacrimal Gland Mantle Cell Lymphoma in 11-Year Follow-Up: Case Report and Review of 48 Cases With Ocular Adnexal Presentation in the Literature. Matsuo T; Tanaka T; Okada K; Notohara K; Fujii K; Fujii N J Investig Med High Impact Case Rep; 2023; 11():23247096231185483. PubMed ID: 37403948 [TBL] [Abstract][Full Text] [Related]
65. Integrating monoclonal antibodies into the management of mantle cell lymphoma. Berinstein NL; Mangel J Semin Oncol; 2004 Feb; 31(1 Suppl 2):2-6. PubMed ID: 15042527 [TBL] [Abstract][Full Text] [Related]
66. In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues. Athanasiou E; Kotoula V; Hytiroglou P; Kouidou S; Kaloutsi V; Papadimitriou CS Mod Pathol; 2001 Feb; 14(2):62-71. PubMed ID: 11235907 [TBL] [Abstract][Full Text] [Related]
67. Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma. Beà S; Amador V Curr Oncol Rep; 2017 Jun; 19(6):43. PubMed ID: 28466437 [TBL] [Abstract][Full Text] [Related]
68. Mantle cell lymphoma: advances in biology and therapy. Smith MR Curr Opin Hematol; 2008 Jul; 15(4):415-21. PubMed ID: 18536582 [TBL] [Abstract][Full Text] [Related]
69. [Ten years progression-free survival obtained in a patient with mantle cell lymphoma]. Wysokińska E; Kolak A; Starosławska E; Kieszko D; Kamińska M; Surdyka D; Mocarska A; Burdan F Pol Merkur Lekarski; 2015 May; 38(227):280-2. PubMed ID: 26039024 [TBL] [Abstract][Full Text] [Related]
70. Combined administration of rituximab and on 013105 induces apoptosis in mantle cell lymphoma cells and reduces tumor burden in a mouse model of mantle cell lymphoma. Prasad A; Shrivastava A; Papadopoulos E; Kuzontkoski PM; Reddy MV; Gillum AM; Kumar R; Reddy EP; Groopman JE Clin Cancer Res; 2013 Jan; 19(1):85-95. PubMed ID: 23124440 [TBL] [Abstract][Full Text] [Related]
71. Mantle cell lymphoma-Update on molecular biology, prognostication and treatment approaches. Silkenstedt E; Dreyling M Hematol Oncol; 2023 Jun; 41 Suppl 1():36-42. PubMed ID: 37294961 [TBL] [Abstract][Full Text] [Related]
72. High-Risk Mantle Cell Lymphoma in the Era of Novel Agents. Nabrinsky E; Danilov AV; Koller PB Curr Hematol Malig Rep; 2021 Feb; 16(1):8-18. PubMed ID: 33507515 [TBL] [Abstract][Full Text] [Related]
74. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients. Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475 [TBL] [Abstract][Full Text] [Related]
75. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents. Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356 [TBL] [Abstract][Full Text] [Related]
76. Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience. Sawalha Y; Hill BT; Rybicki LA; Sun D; Dean RM; Jagadeesh D; Hamilton BK; Gerds AT; Sobecks RM; Andresen S; Liu HK; Majhail NS; Pohlman B; Kalaycio ME; Bolwell BJ; Smith MR Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):e95-e102. PubMed ID: 29208403 [TBL] [Abstract][Full Text] [Related]
78. Mantle cell lymphoma - Current standards of care and future directions. Martin P; Ghione P; Dreyling M Cancer Treat Rev; 2017 Jul; 58():51-60. PubMed ID: 28651117 [TBL] [Abstract][Full Text] [Related]
79. Recent advances and future directions in mantle cell lymphoma research: report of the 2018 mantle cell lymphoma consortium workshop. Kahl BS; Dreyling M; Gordon LI; Martin P; Quintanilla-Martinez L; Sotomayor EM Leuk Lymphoma; 2019 Aug; 60(8):1853-1865. PubMed ID: 30696305 [TBL] [Abstract][Full Text] [Related]
80. Autologous transplantation and management of younger patients with mantle cell lymphoma. Geisler CH Best Pract Res Clin Haematol; 2012 Jun; 25(2):211-20. PubMed ID: 22687457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]